Vascepa is a prescription medication used to treat high levels of triglycerides in the blood. The drug contains a purified form of eicosapentaenoic acid (EPA), which is an omega-3 fatty acid found in fish oil. The benefits of Vascepa program are numerous, and they include a reduction in the risk of cardiovascular events, such as heart attack and stroke, and a decrease in the need for invasive procedures like angioplasty or bypass surgery [1].

One of the primary benefits of Vascepa is its ability to reduce the risk of cardiovascular events. According to a study published in the New England Journal of Medicine, patients who took Vascepa had a 25% reduction in the risk of cardiovascular events compared to those who took a placebo [2]. Another study published in the American Journal of Managed Care found that Vascepa was particularly effective in reducing the risk of cardiovascular events in patients with diabetes [3].

In addition to reducing the risk of cardiovascular events, Vascepa has also been shown to decrease the need for invasive procedures like angioplasty or bypass surgery. According to the same study published in the New England Journal of Medicine, patients who took Vascepa had a 31% reduction in the need for invasive procedures compared to those who took a placebo [2].

Overall, the benefits of Vascepa program are significant for patients with high levels of triglycerides in the blood. The drug has been shown to reduce the risk of cardiovascular events and decrease the need for invasive procedures, making it an important treatment option for those at risk of heart disease [1].

Sources:
[1] https://www.vascepa.com/benefits/
[2] https://www.nejm.org/doi/full/10.1056/NEJMoa1812792
[3] https://www.ajmc.com/view/cardiovascular-benefits-of-vascepa-greater-for-those-with-diabetes-new-reduceit-data-show